Skip to content
GLP-1 Scorecard
Menu
Graded #320

Nava Health

Nava Health is a functional and integrative medicine practice offering its NavaRX medical weight loss program with GLP-1 medications (semaglutide and tirzepatide, brand or compounded).

Visit Nava HealthWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Yes

Line Nava Health up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value45/100
Dose & formulation53/100
Clinical oversight80/100
Labs & monitoring73/100
Fulfillment62/100
Contract terms55/100

Strengths

  • Integrative functional-medicine approach with advanced lab testing
  • Both telemedicine and in-person options
  • Board-certified MDs, DOs, NPs, PAs, and nutritionists
  • Offers both brand and compounded GLP-1 formulations
  • Financing and membership plans available

Where it loses points

  • No published GLP-1 medication pricing online
  • Consultation plus lab work adds to total cost
  • Bundled integrative model costs more than medication-only platforms
  • State availability for telehealth not clearly listed

Bottom line — Grade C

Best for: People wanting GLP-1 weight loss inside a functional-medicine program with lab testing and coaching.

Ranked #320 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Nava Health — the realistic shortlist.

The 21 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Nava Health's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Nava Health's site. Not medical advice; see our disclosure.

← Back to the scorecard